Association of α-adducin Gly460Trp polymorphism with coronary artery disease in a Korean population

Journal of Hypertension

Volumn 25, Issue 12, 2007, Pages 2413-2420

  Cha, Seung Hun ^a   Kim, Hung Tae ^a   Jang, Yangsoo ^b   Park, Sungha ^b   Kim, Jae Jung ^e   Song, Min Young ^a   Park, Jin Hyoung ^a   Ryu, Ha Jung ^e   Park, Hyun Young ^b   Yoon, Sung Joo Kim ^c   Kimm, Kuchan ^d   Lee, Jong Keuk ^e   Oh, Bermseok ^a,f  

^a Korea National Institute of Health   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Eulji University School of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f National Genome Research Institute   (South Korea)

Author keywords

adducin; ADD1; Coronary artery disease; Hypertension; Korean; Single nucleotide polymorphism

Indexed keywords

ALPHA ADDUCIN; GLYCINE; TRYPTOPHAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DNA SEQUENCE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; AMINO ACID SUBSTITUTION; CALMODULIN-BINDING PROTEINS; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 35848952289     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282efedb5     Document Type: Article

References (27)

1. Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36:1859-1863.
2. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE, Hennekens CH. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95:1132-1137.
3. Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV, et al. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27:781-787.
4. Bell RA, Mayer-Davis EJ, Martin MA, D'Agostino RB Jr, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23:1630-1636.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
6. Oparil S. Management of the hypertensive patient with coronary artery disease. Am J Hypertens 1999; 12:56S-62S.
7. Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience). Am J Cardiol 1996; 77:6B-11B.
8. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucl Acids Res 1997; 25:2745-2751.
9. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14:143-149.
10. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117:331-341.
11. Jung HY, Park JS, Park YJ, Kim YJ, Kimm K, Koh IS. HapAnalyzer: minimum haplotype analysis system for association studies. Genom Inform 2004; 2:107-109.
12. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353-1357.
13. Morrison AC, Bray MS, Folsom AR, Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension 2002; 39:1053-1057.
14. Guo X, Cheng S, Taylor KD, Cui J, Hughes R, Quinones MJ, et al. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 2005; 45:799-803.
15. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, et al. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 2004; 25:459-467.
16. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension 2005; 45:331-340.
17. Beeks E, Janssen RG, Kroon AA, Keulen ET, Geurts JM, de Leeuw PW, de Bruin TW. Association between the alpha-adducin Gly460Trp polymorphism and systolic blood pressure in familial combined hyperlipidemia. Am J Hypertens 2001; 14:1185-1190.
18. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, Staessen JA. Cardiovascular risk in relation to alpha-adducin Gly460Trp polymorphism and systolic pressure: a prospective population study. Hypertension 2005; 46:527-532.
19. Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, et al. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther 1999; 288:1074-1083.
20. Manunta P, Barlassina C, Bianchi G. Adducin in essential hypertension. FEBS Lett 1998; 430:41-44.
21. Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams GH. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension 2002; 39:191-196.
22. Barlassina C, Schork NJ, Manunta P, Citterio L, Sciarrone M, Lanella G, et al. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000; 57:1083-1090.
23. Sugimoto K, Hozawa A, Katsuya T, Matsubara M, Ohkubo T, Tsuji I, et al. alpha-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J Hypertens 2002; 20:1779-1784.
24. Ju Z, Zhang H, Sun K, Song Y, Lu H, Hui R, Huang X. Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. J Hypertens 2003; 21:1861-1868.
25. Barlassina C, Norton GR, Samani NJ, Woodwiss AJ, Candy GC, Radevski I, et al. Alpha-adducin polymorphism in hypertensives of South African ancestry. Am J Hypertens 2000; 13:719-723.
26. Castellano M, Barlassina C, Muiesan ML, Beschi M, Cinelli A, Rossi F, et al. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population. J Hypertens 1997; 15:1707-1710.
27. Kamitani A, Wong ZY, Fraser R, Davies DL, Connor JM, Foy CJ, et al. Human alpha-adducin gene, blood pressure, and sodium metabolism. Hypertension 1998; 32:138-143.